Article
Targeting claudin-4 enhances chemosensitivity of triple negative breast cancer
2019-08-04
Abstract excerpt
<title>Abstract</title> <p>Background Triple negative breast cancer (TNBC) possesses highly aggressive phenotype, treatment with limited options, and a poor prognosis. In this study, we examined the therapeutic effect of anti-claudin (CLDN)-4 extracellular domain antibody, 4D3, on TNBC. Methods The expression of CLDN4 and CLDN1 in invasive ductal carcinoma (IDC) was examined in 78 IDCs (from 2004 to 2009 in a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4acd7da2-2a54-58fb-abfd-679ca9e3f289
- DOI
- 10.21203/rs.2.12416/v1
